deltatrials
Terminated NA INTERVENTIONAL 2-arm NCT00720096

Genomic Directed Salvage Chemotherapy With Either Liposomal Doxorubicin Or Topotecan

A Pilot Prospective Trial Of Genomic Directed Salvage Chemotherapy With Either Liposomal Doxorubicin Or Topotecan In Recurrent Or Persistent Ovarian Cancer Within 12 Months Of Platinum-Based Chemotherapy

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Conditions Ovarian Cancer
Interventions Liposomal Doxorubicin Topotecan
Updated 7 times since 2017 Last updated: Dec 8, 2017 Started: Jul 31, 2008 Primary completion: Oct 31, 2009 Completion: Oct 31, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Funds for this project have been spent, and it is thereby terminated.

Other terminated trials from H. Lee Moffitt Cancer Center and Research Institute

See all terminations from H. Lee Moffitt Cancer Center and Research Institute

Other Ovarian Cancer trials with similar outcome

Browse all Ovarian Cancer trials

This NA trial investigates Ovarian Cancer and is currently terminated or withdrawn. H. Lee Moffitt Cancer Center and Research Institute leads this study, which shows 7 recorded versions since 2008 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotTerminated~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Dec 2021 — Jul 2024 [monthly]

    Terminated NA

  4. Jan 2021 — Dec 2021 [monthly]

    Terminated NA

  5. Jun 2018 — Jan 2021 [monthly]

    Terminated NA

▶ Show 2 earlier versions

  1. Feb 2017 — Jun 2018 [monthly]

    Terminated NA

  2. Jan 2017 — Feb 2017 [monthly]

    Terminated NA

    First recorded

Jul 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • H. Lee Moffitt Cancer Center and Research Institute
  • United States Department of Defense
Data source: H. Lee Moffitt Cancer Center and Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations